These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
88 related items for PubMed ID: 6145828
21. Intracranial dissemination of an ACTH secreting pituitary neoplasm--a case report and review of the literature. Tonner D, Belding P, Moore SA, Schlechte JA. J Endocrinol Invest; 1992 May; 15(5):387-91. PubMed ID: 1324266 [Abstract] [Full Text] [Related]
22. Structure and function of somatostatin receptors in growth hormone control. Shimon I, Melmed S. J Endocrinol; 1997 Oct; 155 Suppl 1():S3-6; discussion S7-8. PubMed ID: 9389989 [Abstract] [Full Text] [Related]
23. [Treatment of pituitary adenomas]. Mezosi E, Nemes O. Orv Hetil; 2009 Sep 27; 150(39):1803-10. PubMed ID: 19758960 [Abstract] [Full Text] [Related]
24. Distribution and functionality of the somatostatin receptor subtypes in acromegaly. Saveanu A, Gunz G, Dufour H, Enjalbert A, Culler MD, Jaquet P. J Endocrinol Invest; 2003 Sep 27; 26(8 Suppl):4-7. PubMed ID: 15233203 [No Abstract] [Full Text] [Related]
25. 111In-octreotide scintigraphy in endocrine tumors. Preliminary data. Cremonini N, Furno A, Sforza A, Chiarini V, Graziano E, Zampa G, Turba E. Q J Nucl Med; 1995 Dec 27; 39(4 Suppl 1):116-20. PubMed ID: 9002767 [Abstract] [Full Text] [Related]
26. Sustained remission of Nelson's syndrome after stopping cyproheptadine treatment. Aronin N, Krieger DT. N Engl J Med; 1980 Feb 21; 302(8):453-5. PubMed ID: 6243392 [No Abstract] [Full Text] [Related]
27. Successful pregnancy in an infertile woman with a thyrotropin-secreting macroadenoma treated with somatostatin analog (octreotide). Caron P, Gerbeau C, Pradayrol L, Simonetta C, Bayard F. J Clin Endocrinol Metab; 1996 Mar 21; 81(3):1164-8. PubMed ID: 8772594 [Abstract] [Full Text] [Related]
28. [Drug and radiotherapy of pituitary tumors]. Yoshida H, Takeda F, Kinouchi T, Shimizu N. Nihon Rinsho; 1986 Mar 21; 44(3):659-66. PubMed ID: 3016373 [No Abstract] [Full Text] [Related]
29. Thyrotropin-secreting pituitary adenoma in an adolescent boy: challenges in management. Kessler M, David R, Pawelczak M, Hanono A, Shah B. Pediatrics; 2010 Aug 21; 126(2):e474-8. PubMed ID: 20624809 [Abstract] [Full Text] [Related]
30. Repeated remissions of Cushing's disease due to recurrent infarctions of an ACTH-producing pituitary macroadenoma. Alarifi A, Alzahrani AS, Salam SA, Ahmed M, Kanaan I. Pituitary; 2005 Aug 21; 8(2):81-7. PubMed ID: 16195779 [Abstract] [Full Text] [Related]
31. Long term treatment with the somatostatin analog SMS 201-995 in a patient with a thyrotropin- and growth hormone-secreting pituitary adenoma. Wémeau JL, Dewailly D, Leroy R, D'Herbomez M, Mazzuca M, Decoulx M, Jaquet P. J Clin Endocrinol Metab; 1988 Mar 21; 66(3):636-9. PubMed ID: 2895119 [Abstract] [Full Text] [Related]
32. A cyproheptadine-reversible defect in ACTH control persisting after removal of the pituitary tumor in Cushing's disease. Lankford HV, Tucker HS, Blackard WG. N Engl J Med; 1981 Nov 19; 305(21):1244-8. PubMed ID: 6270557 [Abstract] [Full Text] [Related]
33. Significant gene expression of insulin-like growth factor II and proliferating cell nuclear antigen in a rapidly growing recurrent pituitary acth-secreting adenoma. Hashimoto K, Nagano I, Asaba K, Inoue M, Nishioka T, Takao T, Nakajo T, Mori T, Kurisaka M, Otsuka F. Horm Res; 2000 Nov 19; 54(4):198-202. PubMed ID: 11416238 [Abstract] [Full Text] [Related]
34. Bim-23244, a somatostatin receptor subtype 2- and 5-selective analog with enhanced efficacy in suppressing growth hormone (GH) from octreotide-resistant human GH-secreting adenomas. Saveanu A, Gunz G, Dufour H, Caron P, Fina F, Ouafik L, Culler MD, Moreau JP, Enjalbert A, Jaquet P. J Clin Endocrinol Metab; 2001 Jan 19; 86(1):140-5. PubMed ID: 11231991 [Abstract] [Full Text] [Related]
35. The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro. Hofland LJ, van der Hoek J, van Koetsveld PM, de Herder WW, Waaijers M, Sprij-Mooij D, Bruns C, Weckbecker G, Feelders R, van der Lely AJ, Beckers A, Lamberts SW. J Clin Endocrinol Metab; 2004 Apr 19; 89(4):1577-85. PubMed ID: 15070915 [Abstract] [Full Text] [Related]
36. [Somatostatin analogs in the clinical management of pituitary neoplasms]. Colao A, Dorato M, Pulcrano M, Rossi FW, Auriemma RS, Lombardi G, Lastoria S. Minerva Endocrinol; 2001 Sep 19; 26(3):181-91. PubMed ID: 11753242 [Abstract] [Full Text] [Related]
37. An infant with Cushing's disease due to an adrenocorticotropin-producing pituitary adenoma. Miller WL, Townsend JJ, Grumbach MM, Kaplan SL. J Clin Endocrinol Metab; 1979 Jun 19; 48(6):1017-25. PubMed ID: 221523 [Abstract] [Full Text] [Related]
38. Current concepts in cancer: management of hormone-secreting pituitary adenomas. Zervas NT, Martin JB. N Engl J Med; 1980 Jan 24; 302(4):210-4. PubMed ID: 6985705 [No Abstract] [Full Text] [Related]
39. [Transsphenoidal hypophysectomy of a patient with an ACTH-producing pituitary adenoma and an "empty sella" after pretreatment with etomidate]. Herrmann BL, Mitchell A, Saller B, Stolke D, Forsting M, Frilling A, Mann K. Dtsch Med Wochenschr; 2001 Mar 02; 126(9):232-4. PubMed ID: 11256037 [Abstract] [Full Text] [Related]
40. ACTH-producing pituitary tumors. Grua JR, Nelson DH. Endocrinol Metab Clin North Am; 1991 Jun 02; 20(2):319-62. PubMed ID: 1652434 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]